[go: up one dir, main page]

HU0103939D0 - Pharmaceutical composition containing methformin and n-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride - Google Patents

Pharmaceutical composition containing methformin and n-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride

Info

Publication number
HU0103939D0
HU0103939D0 HU0103939A HUP0103939A HU0103939D0 HU 0103939 D0 HU0103939 D0 HU 0103939D0 HU 0103939 A HU0103939 A HU 0103939A HU P0103939 A HUP0103939 A HU P0103939A HU 0103939 D0 HU0103939 D0 HU 0103939D0
Authority
HU
Hungary
Prior art keywords
methformin
piperidinyl
propoxy
pyridine
hydroxy
Prior art date
Application number
HU0103939A
Other languages
Hungarian (hu)
Inventor
Biro Katalin Dr
Andrea Jednakovits
Maria Kuerthy
Tamas Mogyorosi
Ueroegdi Laszlo Dr
Csakai Zita Jegesne
Timea Racz
Original Assignee
Biorex Kutato Fejlesztoe Kft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biorex Kutato Fejlesztoe Kft filed Critical Biorex Kutato Fejlesztoe Kft
Priority to HU0103939A priority Critical patent/HU0103939D0/en
Publication of HU0103939D0 publication Critical patent/HU0103939D0/en
Priority to PCT/HU2002/000098 priority patent/WO2003026653A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/4523—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems
    • A61K31/4545—Non condensed piperidines, e.g. piperocaine containing further heterocyclic ring systems containing a six-membered ring with nitrogen as a ring hetero atom, e.g. pipamperone, anabasine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Engineering & Computer Science (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
HU0103939A 2001-09-27 2001-09-27 Pharmaceutical composition containing methformin and n-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride HU0103939D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
HU0103939A HU0103939D0 (en) 2001-09-27 2001-09-27 Pharmaceutical composition containing methformin and n-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride
PCT/HU2002/000098 WO2003026653A1 (en) 2001-09-27 2002-09-26 Pharmaceutical composition comprising metformin and n-`2-hydroxy-3-(1-piperidinyl)-propoxy! pyridine-1-oxide-3-carboximidoyl chloride

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
HU0103939A HU0103939D0 (en) 2001-09-27 2001-09-27 Pharmaceutical composition containing methformin and n-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride

Publications (1)

Publication Number Publication Date
HU0103939D0 true HU0103939D0 (en) 2001-11-28

Family

ID=89979729

Family Applications (1)

Application Number Title Priority Date Filing Date
HU0103939A HU0103939D0 (en) 2001-09-27 2001-09-27 Pharmaceutical composition containing methformin and n-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride

Country Status (2)

Country Link
HU (1) HU0103939D0 (en)
WO (1) WO2003026653A1 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP0303584A3 (en) * 2003-10-30 2009-12-28 Cytrx Corp Use of a hydroximic acid halide derivative in the treatment of neurodegenerative diseases
EP1752147A4 (en) * 2004-06-04 2007-10-31 Kowa Co MEDICINE FOR THE PREVENTION OR TREATMENT OF DIABETES
US20080227813A1 (en) * 2006-09-26 2008-09-18 Jack Raymond Barber Pharmaceutical compositions and methods for treating diseases associated with neurodegeneration
TW200901958A (en) * 2007-05-04 2009-01-16 Cytrx Corp Diabetic wound healing
AU2009262670B2 (en) 2008-06-26 2013-06-20 Zevra Denmark A/S Use of Hsp70 as a regulator of enzymatic activity
US9662375B2 (en) 2010-11-30 2017-05-30 Orphazyme Aps Methods for increasing intracellular activity of Hsp70
KR102638203B1 (en) * 2014-09-15 2024-02-19 제브라 덴마크 에이/에스 Arimoclomol formulation
WO2017178029A1 (en) 2016-04-13 2017-10-19 Orphazyme Aps Heat shock proteins and cholesterol homeostasis
SMT202100022T1 (en) 2016-04-29 2021-03-15 Orphazyme As Arimoclomol for treating glucocerebrosidase associated disorders
KR20230128462A (en) 2020-11-19 2023-09-05 제브라 덴마크 에이/에스 Process for preparing arimoclomol citrate and intermediates thereof

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HUP9900475D0 (en) * 1999-02-26 1999-04-28 Biorex Kutato Fejlesztoe Kft O-(3-piperidino-2-hydroxy-1-propyl)-hiyroximic acid-halogenid derivative, it's use for treating insulin resistance, and pharmaceutical compositions containing them as active component
HUP0001583A2 (en) * 2000-04-18 2002-11-28 BIOREX Kutató és Fejlesztő Rt. A pyridine-1-oxide derivative and process for its conversion to medicinal compounds

Also Published As

Publication number Publication date
WO2003026653A1 (en) 2003-04-03

Similar Documents

Publication Publication Date Title
HUS1400025I1 (en) Phenethanolamine derivatives and pharmaceutical composition containing them
HUP0402236A3 (en) Heterocyclic compounds pharmaceutical compounds containing thereof and use thereof
HUP0303325A3 (en) Pharmaceutical salts and pharmaceutical compositions containing them
HUP0400974A3 (en) Peptide-based compounds and pharmaceutical compositions containing them
IL209444A0 (en) O-desmethyl-venlafaxine succinate salts and pharmaceutical compositions containing them
HUP0400052A3 (en) Carboxamide-substituted phenylurea derivatives and pharmaceutical compositions containing them and their use
IL155196A0 (en) Benzamide derivatives and pharmaceutical compositions containing the same
IL157029A0 (en) Azaindoleoxoacetic piperazine derivatives and pharmaceutical compositions containing the same
HUP0301269A3 (en) Phthalazinone derivatives and pharmaceutical compositions containing them
HUP0401567A3 (en) Novel 4,5-dyhydro-1h-pyrazole derivatives having cb1-antagonistic activity, their use and pharmaceutical compositions containing them
HUP0302845A3 (en) 4-fluoro-n-indan-2-yl benzamide and its use as pharmaceutical
HUP0203939A3 (en) Pharmaceutical compounds and compositions containing them and their use
HUP0400384A3 (en) Benzamidine derivative and pharmaceutical compositions containing them and their use
HUP0401333A3 (en) Spiropyrazole compounds and pharmaceutical compositions containing them
IL158300A0 (en) Bisarylimidazol derivatives and pharmaceutical compositions containing the same
IL158044A0 (en) Cyclopropylindole derivatives and pharmaceutical compositions containing the same
HUP0303998A3 (en) Phthalazinones derivatives and pharmaceutical compositions containing them
IL158671A0 (en) Benzyloxy derivatives and pharmaceutical compositions containing the same
SI1411921T1 (en) Pharmaceutical compositions containing terbinafine and use thereof
HUP0401403A3 (en) 2,4-diaminothiazole derivatives, their use and pharmaceutical compositions containing them
HUP0400179A3 (en) 2,5-diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylpyrimidines, their use and pharmaceutical compositions containing them
HUP0105204A3 (en) Substituted phenethylamine derivatives and pharmaceutical compositions containing them
PL369139A1 (en) Deuterated substituted dihydrofuranones and medicaments containing these compounds
HU0103939D0 (en) Pharmaceutical composition containing methformin and n-[2-hydroxy-3-(1-piperidinyl)-propoxy]-pyridine-1-oxide-3-carboximidoyl chloride
HUP0101733A3 (en) Pharmaceutical compositions containing sulfonyl-dipeptides and their use